|
Heterogeneity of Coenzyme Q10Deficiency
|
journal
|
August 2012 |
|
A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit
|
journal
|
May 2014 |
|
The Mismatch Repair Protein MSH2 is Rate Limiting for Repeat Expansion in a Fragile X Premutation Mouse Model
|
journal
|
November 2013 |
|
Mitochondrial-derived reactive oxygen species (ROS) play a causal role in aging-related intervertebral disc degeneration: INTERVETEBRAL DISC OXIDATIVE DAMAGE
|
journal
|
February 2013 |
|
Targeting Expanded Repeats by Small Molecules in Repeat Expansion Disorders
|
journal
|
December 2020 |
|
Management of oxidative stress and other pathologies in Alzheimer’s disease
|
journal
|
August 2019 |
|
Reactive Oxygen Species: Beyond Their Reactive Behavior
|
journal
|
January 2021 |
|
A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington’s Disease
|
journal
|
February 2021 |
|
Antioxidant Combo Therapy Protects White Matter After Traumatic Brain Injury
|
journal
|
January 2021 |
|
Coenzyme Q10 and remacemide hydrochloride ameliorate motor deficits in a Huntington's disease transgenic mouse model
|
journal
|
November 2001 |
|
Effects of coenzyme Q10 administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat
|
journal
|
September 2002 |
|
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
|
journal
|
September 2017 |
|
Oral Coenzyme Q10 Supplementation in Patients with Nonalcoholic Fatty Liver Disease: Effects on Serum Vaspin, Chemerin, Pentraxin 3, Insulin Resistance and Oxidative Stress
|
journal
|
October 2014 |
|
Conditional ablation of reactive astrocytes to dissect their roles in spinal cord injury and repair
|
journal
|
August 2019 |
|
Hemigramicidin–TEMPO conjugates: Novel mitochondria-targeted anti-oxidants
|
journal
|
September 2007 |
|
Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease
|
journal
|
July 2015 |
|
CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset
|
journal
|
August 2019 |
|
Targeting of XJB-5-131 to Mitochondria Suppresses Oxidative DNA Damage and Motor Decline in a Mouse Model of Huntington’s Disease
|
journal
|
November 2012 |
|
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration
|
journal
|
November 2006 |
|
Metabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice
|
journal
|
June 2019 |
|
Secondary coenzyme Q deficiency in neurological disorders
|
journal
|
March 2021 |
|
Evaluation of cytotoxicity of oils used in coenzyme Q10 Self-Emulsifying Drug Delivery Systems (SEDDS)
|
journal
|
April 2004 |
|
The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington’s disease
|
journal
|
January 2017 |
|
Coenzyme Q10 supplementation – In ageing and disease
|
journal
|
July 2021 |
|
Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease
|
journal
|
February 2012 |
|
Small molecules as therapeutic drugs for Alzheimer's disease
|
journal
|
April 2019 |
|
Coenzyme Q, oxidative stress and aging
|
journal
|
June 2007 |
|
Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes
|
journal
|
January 2009 |
|
Advancing the health of our aging population: A lead role for nursing science
|
journal
|
July 2011 |
|
Regulation of hepatic coenzyme Q biosynthesis by dietary omega-3 polyunsaturated fatty acids
|
journal
|
October 2021 |
|
Protective Effect of Natural Products against Huntington’s Disease: An Overview of Scientific Evidence and Understanding Their Mechanism of Action
|
journal
|
January 2021 |
|
Targeting Mitochondria
|
journal
|
January 2008 |
|
Superoxide Dismutases and Superoxide Reductases
|
journal
|
January 2014 |
|
Mitochondrial Targeting of Selective Electron Scavengers: Synthesis and Biological Analysis of Hemigramicidin−TEMPO Conjugates
|
journal
|
September 2005 |
|
Characterization of Hydantoin Products from One-Electron Oxidation of 8-Oxo-7,8-dihydroguanosine in a Nucleoside Model
|
journal
|
July 2001 |
|
Pivotal Role for Two Electron Reduction in 2,3-Dimethoxy-1,4-naphthoquinone and 2-Methyl-1,4-naphthoquinone Metabolism and Kinetics in Vivo That Prevents Liver Redox Stress
|
journal
|
April 2009 |
|
Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice
|
journal
|
December 1999 |
|
MutSβ promotes trinucleotide repeat expansion by recruiting DNA polymerase β to nascent (CAG)n or (CTG)n hairpins for error-prone DNA synthesis
|
journal
|
June 2016 |
|
Double setback for ASO trials in Huntington disease
|
journal
|
May 2021 |
|
Failure of genetic therapies for Huntington’s devastates community
|
journal
|
May 2021 |
|
OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells
|
journal
|
April 2007 |
|
Crosstalk between MSH2–MSH3 and polβ promotes trinucleotide repeat expansion during base excision repair
|
journal
|
August 2016 |
|
Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury
|
journal
|
August 2012 |
|
(CAG)n-hairpin DNA binds to Msh2–Msh3 and changes properties of mismatch recognition
|
journal
|
July 2005 |
|
XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia−reperfusion injury
|
journal
|
August 2020 |
|
Prevalence of Parkinson’s disease across North America
|
journal
|
July 2018 |
|
Plasma coenzyme Q10 status is impaired in selected genetic conditions
|
journal
|
January 2019 |
|
Extrahelical (CAG)/(CTG) triplet repeat elements support proliferating cell nuclear antigen loading and MutL endonuclease activation
|
journal
|
July 2013 |
|
Human MutLγ, the MLH1–MLH3 heterodimer, is an endonuclease that promotes DNA expansion
|
journal
|
February 2020 |
|
Coordination between Polymerase β and FEN1 Can Modulate CAG Repeat Expansion
|
journal
|
August 2009 |
|
Emerging therapeutics in Huntington’s disease
|
journal
|
July 2021 |
|
Coenzyme Q10 and the exclusive club of diseases that show a limited response to treatment
|
journal
|
May 2021 |
|
CTG repeat instability and size variation timing in DNA repair-deficient mice
|
journal
|
May 2003 |
|
Neurological abnormalities in a knock-in mouse model of Huntington's disease
|
journal
|
January 2001 |
|
Somatic expansion behaviour of the (CTG)n repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins
|
journal
|
January 2002 |
|
Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice
|
journal
|
March 2000 |
|
Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes
|
journal
|
February 2016 |
|
A modifier of Huntington's disease onset at the MLH1 locus
|
journal
|
July 2017 |
|
Somatic CAG expansion in Huntington's disease is dependent on the MLH3 endonuclease domain, which can be excluded via splice redirection
|
journal
|
March 2021 |
|
Perfluorooctane Sulfonate (PFOS) Produces Dopaminergic Neuropathology in Caenorhabditis elegans
|
journal
|
August 2019 |
|
Mitochondria‐targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants
|
journal
|
August 2003 |
|
Mitochondria‐targeted antioxidants
|
journal
|
August 2015 |
|
Treatment With a Novel Hemigramicidin-TEMPO Conjugate Prolongs Survival in a Rat Model of Lethal Hemorrhagic Shock
|
journal
|
January 2007 |
|
Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges
|
journal
|
February 2020 |
|
Huntington's disease: a clinical review
|
journal
|
September 2017 |
|
Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failure
|
journal
|
May 2009 |
|
Combination therapy with Coenzyme Q10and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases
|
journal
|
June 2009 |
|
Mitochondrial-Targeted Antioxidants Attenuate TGF-β2 Signaling in Human Trabecular Meshwork Cells
|
journal
|
August 2019 |
|
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease
|
journal
|
January 2007 |
|
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
|
journal
|
December 2016 |
|
A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease
|
journal
|
August 2001 |
|
Effects of Anthocyanins on CAG Repeat Instability and Behaviour in Huntington’s Disease R6/1 Mice
|
journal
|
January 2016 |
|
Deletion of the Huntingtin Polyglutamine Stretch Enhances Neuronal Autophagy and Longevity in Mice
|
journal
|
February 2010 |
|
MSH3 Polymorphisms and Protein Levels Affect CAG Repeat Instability in Huntington's Disease Mice
|
journal
|
February 2013 |
|
Mismatch Repair Genes Mlh1 and Mlh3 Modify CAG Instability in Huntington's Disease Mice: Genome-Wide and Candidate Approaches
|
journal
|
October 2013 |
|
Heterozygosity for a Hypomorphic Polβ Mutation Reduces the Expansion Frequency in a Mouse Model of the Fragile X-Related Disorders
|
journal
|
April 2015 |
|
Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington’s Disease
|
journal
|
August 2015 |
|
Comprehensive Behavioral Testing in the R6/2 Mouse Model of Huntington's Disease Shows No Benefit from CoQ10 or Minocycline
|
journal
|
March 2010 |
|
Pms2 Suppresses Large Expansions of the (GAA·TTC)n Sequence in Neuronal Tissues
|
journal
|
October 2012 |
|
MutLα Heterodimers Modify the Molecular Phenotype of Friedreich Ataxia
|
journal
|
June 2014 |
|
HdhQ111 Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid Accumulation
|
journal
|
August 2015 |
|
XJB-5-131-mediated improvement in physiology and behaviour of the R6/2 mouse model of Huntington's disease is age- and sex- dependent
|
journal
|
April 2018 |
|
GS-Nitroxide (JP4-039)-Mediated Radioprotection of Human Fanconi Anemia Cell Lines
|
journal
|
November 2011 |
|
Targeting Mitochondrial Dysfunction and Neurodegeneration by Means of Coenzyme Q10 and its Analogues
|
journal
|
September 2011 |
|
Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease
|
journal
|
February 2022 |
|
DNA Mismatch Repair and its Role in Huntington’s Disease
|
journal
|
February 2021 |
|
The Use of Coenzyme Q10 in Cardiovascular Diseases
|
journal
|
May 2021 |
|
CoQ10 and Aging
|
journal
|
May 2019 |
|
Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders
|
journal
|
January 2021 |
|
Intracellular Sources of ROS/H2O2 in Health and Neurodegeneration: Spotlight on Endoplasmic Reticulum
|
journal
|
January 2021 |
|
Disorders of Human Coenzyme Q10 Metabolism: An Overview
|
journal
|
September 2020 |
|
Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases
|
journal
|
September 2020 |
|
Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain
|
journal
|
December 2020 |
|
CoQ10 Deficient Endothelial Cell Culture Model for the Investigation of CoQ10 Blood–Brain Barrier Transport
|
journal
|
October 2020 |
|
Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients
|
journal
|
October 2020 |
|
Prolonged Intake of Coenzyme Q10 Impairs Cognitive Functions in Mice
|
journal
|
August 2009 |
|
Aducanumab: The first targeted Alzheimer's therapy
|
journal
|
June 2021 |
|
Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage
|
journal
|
January 2007 |